StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) income statement

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.22−0.28 (-6.22%)

Close on Nov 20, 2026Market cap $52.99MP/E –Yield –

Neuraxis, INC income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
85.6%
Operating margin
-144.5%
Net margin
-144.4%
Return on equity, FY2025
-285.4%

Financial strength

Current ratio
3.04
Debt to equity
–
Debt to assets
–
Cash to current liabilities
268.8%

Valuation

P/E ratio
–
Price to sales
9.97
Price to book
7.87
Dividend yield
–

See a number that looks wrong?